{"nct_id":"NCT05559359","title":"A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2022-10-18","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}